<DOC>
	<DOCNO>NCT01419561</DOCNO>
	<brief_summary>Background : - KSHV inflammatory cytokine syndrome ( KICS ) newly recognize disease cause Kaposi sarcoma-associated herpesvirus ( KSHV ) . This virus cause cancer . People KICS severe symptom . They include fever , weight loss , fluid legs abdomen . People KICS may also risk get cancer associate KSHV . These cancer include Kaposi sarcoma lymphoma . Because KICS newly identify disease , information need disease work do treat . Objectives : - To collect genetic medical information people KSHV inflammatory cytokine syndrome . Eligibility : - Individuals least 18 year age Kaposi sarcoma herpes virus symptom resemble caused KICS . Design : - Participants regular study visit . The schedule determine study researcher . - Participants provide complete medical history full physical exam . Blood urine sample collect well . - People KICS require treatment may get new experimental treatment . These treatment may include antiviral drug chemotherapy drug , depend nature disease . - Participants image study , chest x-ray compute tomography scan , study tumor . - Bone marrow lymph node biopsy may do collect tissue sample study . - Participants Kaposi sarcoma photograph take lesion .</brief_summary>
	<brief_title>History KSHV Inflammatory Cytokine Syndrome ( KICS )</brief_title>
	<detailed_description>BACKGROUND : KSHV inflammatory cytokine syndrome ( KICS ) newly recognize syndrome cause Kaposi sarcoma-associated herpesvirus ( KSHV ) . It characterize severe inflammatory symptom include fever , waste , cytopenia , hypoalbuminemia , hyponatremia , associate case lymphadenopathy effusion , without pathological evidence MCD . Patients KICS exhibit elevate KSHV viral load cytokine dysregulation , elevation IL-6 , IL-10 , KSHV-encoded IL-6 homolog , viral IL-6 . OBJECTIVES : The primary study objective enable intensive study description natural history KICS . Secondary objective include assessment affected person KSHV viral load cytokine level , evaluation tissue pathophysiology , exploration FDG-PET abnormality , pilot assessment response two therapy : high dose zidovudine/valganciclovir rituximab/liposomal doxorubicin . ELIGIBILITY : Adults HIV status : - At least two symptom , laboratory radiographic abnormality least possibly attributable KICS ( include fever , fatigue , cachexia , edema , respiratory gastrointestinal symptom , hematologic cytopenia , hypoalbuminemia , hyponatremia , lymphadenopathy , organomegaly , effusion ) - C-reactive protein &gt; 3mg/dL . - Evidence KSHV infection risk exposure KSHV infection - No evidence KSHV-associated multicentric Castleman disease Patients characteristic evaluate identify whose clinical laboratory feature consistent work KICS work case definition follow natural history phase study . DESIGN : This single center natural history cohort observation arm two nest open label pilot treatment arm , accrual ceiling 40 patient overall natural history arm . Natural history patient undergo clinical , laboratory correlative assessment every 3 month sustain resolution . Patients clinical laboratory manifestation KICS , elevate inflammatory marker KSHV viral load eligible therapy high dose zidovudine/valganciclovir , intercurrent KS require cytotoxic therapy , rituximab/liposomal doxorubicin . Each treatment arm use two stage design , interim analysis 8 patient arm potential accrual 14 per arm .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<criteria>INCLUSION CRITERIA : Age great equal to18 Years . Any HIV status . At least two manifestation draw least two category ( clinical symptom , laboratory abnormality radiographic abnormality ) , least possibly attributable KICS readily explicable know medical condition patient : Clinical symptom ( least grade 1 CTCAE definition ) Fever ( &gt; 38 degree C ) , chill rigor Fatigue lethargy Cachexia edema Cough , dyspnea , airway hyperreactivity , nasal inflammation Nausea , anorexia , abdominal pain alter bowel habit Athralgia myalgia Altered mental state Neuropathy without pain Laboratory abnormality Anemia ( hemoglobin &lt; 12.0g/dL ) Thrombocytopenia ( platelet &lt; 100,000 cells/microL ) Leukopenia ( white cell count &lt; 4,000 cells/microL ) Hypoalbuminemia ( albumin &lt; 3.5g/dL ) Hyponatremia ( sodium &lt; 135mmol/L ) Coagulopathy ( PT PTT &gt; 1.5 time upper limit normal ) Pathologic lymphadenopathy ( least five discrete node &gt; 1cm long dimension ) Splenomegaly ( &gt; 12 cm long dimension ) Hepatomegaly ( &gt; 17cm long dimension ) Body cavity effusion cause primary effusion lymphoma chylous effusion directly relate lymphatic infiltration KS . Creactive protein &gt; 3mg/dl . Exposure risk KSHV infection ( include first second generation immigrant endemic area , maletomale sexual activity ) evidence KSHV infection demonstrate one : Molecular evidence KSHV whole blood , confirm test Focus Laboratories , CA ( HHV8 Quantitative PCR , Focus Unit Code 45700 ) . Immunohistochemical evidence KSHV tissue ( example stain LANA vIL6 ) . Confirmed Laboratory Pathology , CCR , NCI . Presence KS PEL ( KSHVassociated malignancy ) , confirm Laboratory Pathology , CCR , NCI . EXCLUSION CRITERIA : Biopsy proven KSHVassociated MCD , confirm Laboratory Pathology , CCR , NCI . Pregnancy Any abnormality would score NCI CTC Grade 4 toxicity unrelated HIV , treatment , KICS would preclude use study treatment ability monitor natural history KICS untreated . Any condition set circumstance opinion investigator would make participation study unsafe otherwise inappropriate give individual .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 7, 2016</verification_date>
	<keyword>KSHV</keyword>
	<keyword>KICS</keyword>
	<keyword>HIV</keyword>
	<keyword>Cytokines</keyword>
	<keyword>HHV-8</keyword>
	<keyword>KSHV Inflammatory Cytokine Syndrome</keyword>
	<keyword>Kaposi Sarcoma Heres Virus</keyword>
</DOC>